CD&R/PERMIRA
CD&R and Everest UK HoldCo Limited, an entity controlled by the Permira funds and the majority shareholder of Exclusive Networks, are pleased to announce that they intend to form a consortium with a view to acquire (directly or indirectly, by way of sales and contributions), through a dedicated entity (“BidCo”) the shares of Exclusive Networks held by Everest UK HoldCo Limited and Olivier Breittmayer, representing 66.7% of the share capital and 66.7% of the theoretical voting rights of Exclusive Networks1, at a price of €18.96 per share following payment of the exceptional distribution of €5.29 per share (the “Acquisitions”).
Following the payment of the exceptional distribution of reserves and premia to the shareholders and the closing of the Acquisitions thereafter, BidCo, which will be jointly controlled by CD&R and Everest UK HoldCo Limited, will launch a simplified mandatory tender offer on the Exclusive Networks shares not acquired as part of the Acquisitions, other than the shares held in treasury by the Company, at a price of €18.96 per share (ex-distribution of €5.29 per share attached) (the “Offer”, and together with the Acquisitions the “Proposed Transaction”). BidCo will subsequently request the implementation of a squeeze-out if the legal conditions are met at the end of the Offer.
This price of €24.25 per Exclusive Networks share (with right to exceptional distribution attached) would reflect a 34.4% premium to the undisturbed share price of €18.04 as of 13 March 2024 (being the date prior to initial market rumours) and a premium of 31.3%, 31.9% and 34.1%, respectively, on the volume-weighted 60, 120 and 180 day average share prices2 prior to that date, as well as a premium of 15.5% compared to the all-time high price3 of the Exclusive Networks shares, reached on 17 May 2023.
The Proposed Transaction values 100% of Exclusive Networks’ share capital at €2.2 billion on a fully diluted basis.
The Acquisitions are conditioned upon the receipt of customary regulatory approvals, notably in connection with antitrust, foreign investment control and foreign subsidies in the European Union, the approval of an exceptional distribution in an amount of €5.29 per share by Exclusive Networks’ shareholders, and the payment of such exceptional distribution, financed in part with the proceeds of a new facility to be entered into in the context of the Proposed Transaction.
Gregory Laï, Partner at CD&R, said:
“Over the past decade, Exclusive Networks has grown to become one of the pre-eminent cybersecurity solutions businesses, building a platform to service both leading cybersecurity vendors and thousands of global partners and end-users. CD&R has a long track record in the technology sector, including highly relevant investments in IT services and solutions companies. We see an opportunity to invest in the company’s services and digital capabilities to better serve Exclusive Networks’ community of vendors. We look forward to working with the consortium, the company and its management team, to bring our expertise and partnership approach to Exclusive Networks as it looks to its next chapter of growth.”
Michail Zekkos, Partner and Co-Head of Technology, and Pierre Pozzo, Partner, at Permira, said:
“As the cybersecurity market continues to grow and evolve, Exclusive Networks is well-placed to capitalise on a number of trends including the consolidation of vendor spend and product innovation, requiring greater expertise and channel support. It has been a pleasure to work with Exclusive Networks since 2018 as the company has solidified its position as the one of the leading global cybersecurity specialists. We’d particularly like to thank Jesper and the broader Exclusive Networks team for their hard work and dedication to the company’s disruptive approach and focus on value creation for its partners. We are delighted to welcome CD&R to the consortium; our combined expertise, including CD&R’s long-track record in the IT channel ecosystem as well as Permira’s 35+ years of investing in technology, will be invaluable as we look to support the management team to continue to grow the business in a competitive market.”
Olivier Breittmayer, Founder and Non-Independent Board Member of Exclusive Networks, said:
“This is an exciting milestone in the history of Exclusive Networks. Since I founded the business in 2003, it has gone through a number of evolutions and grown to become one of the leading cybersecurity businesses globally. This reflects the significant contributions from the teams, shareholders, partners, customers and many more over the years. The consortium’s support, expertise and capital will all be critical as we look to continue our growth and capture the compelling opportunities ahead for the business.”
Business Overview and Proposed Transaction rationale
Exclusive Networks plays a critical role in the global cybersecurity value chain. The company serves as a go-to-market and technical service specialist across the globe, providing cybersecurity vendors with access to fragmented national markets, and local partners with the experience and expertise they require to serve their end-customers’ security needs. Exclusive Networks’ global footprint includes offices in over 45 countries and the ability to serve customers in over 170 countries, leveraging a portfolio of cybersecurity products and support services which range from managed security to technical accreditation and training.
Exclusive Networks has grown consistently over its 20+ year history based on secular tailwinds driving cybersecurity demand. The company’s strategy is to provide high-touch services to high-growth cybersecurity vendors through a differentiated model that combines global breadth, local depth and cybersecurity specialization; this strategy has positioned Exclusive Networks as a trusted specialist helping its partners navigate an increasingly complex world of enterprise IT security challenges and solutions.
Today, Exclusive Networks sees the opportunity to further expand its role in the global cyber ecosystem by continuing to maintain and grow the company’s vendor portfolio; by enhancing service offerings to vendors and partners alike; and by sustaining its record of historical M&A. The Proposed Transaction will allow Exclusive Networks to increase its long-term investment in these goals.
The consortium believes that private ownership will allow Exclusive Networks to leverage CD&R’s and Permira’s extensive technology expertise and commitment to investing in the success of portfolio companies. The Proposed Transaction will provide the company with additional capital and resources in order to execute its strategy and better serve its customer base.
Offer unanimously welcomed by Exclusive Networks’ Board of Directors
On July 23, 2024, the Board of Directors of Exclusive Networks unanimously welcomed the Offer without prejudice to the reasoned opinion to be issued by the Board following receipt of the fairness opinion from the independent expert.
In the context of the Offer, the Board of Directors established an ad hoc committee, comprising three independent members: Barbara Thoralfsson, Marie-Pierre de Bailliencourt and Nathalie Lomon.
Upon the recommendation of the ad hoc committee, the Board of Directors has appointed Finexsi, represented by Christophe Lambert, as an independent expert to prepare a fairness opinion on the financial terms of the Offer and has obtained a solvency opinion on the conditions of the exceptional distribution.
In addition, the Company has conducted and finalized the consultation process of the competent employee representative bodies in connection with the Proposed Transaction.
The Board of Directors has also approved the contemplated exceptional distribution of reserves and premia, in an amount of €5.29 per share. The payment of this exceptional distribution will be proposed to the shareholders’ meeting before 30 November 2025 and its payment will take place after the receipt of the regulatory approvals required in the context of the Proposed Transaction.
Key conditions and timetable of the Proposed Transaction
The Acquisitions of the shares held by Everest UK HoldCo Limited and Olivier Breittmayer are conditional on receipt of regulatory clearances, the approval of the exceptional distribution by Exclusive Networks’ shareholders, before March 22, 2025 and the payment of such exceptional distribution with the proceeds of new facility to be entered into in the context of the Proposed Transaction, no later than April 20, 2025, failing which any party may, if applicable, elect not to proceed with the Proposed Transaction. The implementation of the Acquisitions will trigger the obligation for the consortium to launch a mandatory simplified tender offer.
The Acquisitions and the subsequent filing of the Offer are expected to take place at the beginning of 2025.
Disclaimer
This press release has been prepared for information purposes only. It does not constitute an offer to purchase or a solicitation to sell Exclusive Networks shares in any country, including France. There is no certainty that the simplified tender offer mentioned above will be filed or opened. The dissemination, publication or distribution of this press release may be subject to specific regulations or restrictions in certain countries. Accordingly, persons in possession of this press release are required to inform themselves about and to comply with any local restrictions that may apply.
About CD&R
Founded in 1978, CD&R is a leading private investment firm with a strategy of generating strong investment returns by building more robust and sustainable businesses through the combination of skilled investment experience and deep operating capabilities. In partnership with the management teams of its portfolio companies, CD&R takes a long-term view of value creation and emphasizes positive stewardship and impact. The firm invests in businesses that span a broad range of industries, including industrial, healthcare, consumer, technology and financial services end markets. CD&R is privately owned by its partners and has offices in New York and London. For more information, please visit www.cdr-inc.com and follow the firm's activities through LinkedIn and @CDRBuilds on X/Twitter.
About Permira
Permira is a global investment firm that backs successful businesses with growth ambitions. Founded in 1985, the firm advises funds with total committed capital of approximately €80bn and makes long-term majority and minority investments across two core asset classes, private equity and credit.
The Permira private equity funds have make both long-term majority (Buyout) and minority (Growth Equity) investments made approximately 300 private equity investments in four key sectors: Technology, Consumer, Healthcare, and Services. The Permira funds have an extensive track record in technology investing, having invested more than $23 billion in c.80 companies across enterprise cloud adoption, cybersecurity, SaaS, fintech, digital commerce and online marketplaces.
The Permira funds have previously supported and helped scale some of the largest and fastest-growing technology businesses globally, including, Genesys, TeamViewer, Zendesk, McAfee, Mimecast, Carta, G2, Sysdig, Sonar, Mirakl and others.
Permira employs over 500 people in 16 offices across Europe, the United States and Asia. For more information, visit www.permira.com or follow us on LinkedIn.
1 Based on a total number of theoretical voting rights as of 30 June 2024 of 91,670,286.
2 Source: Bloomberg
3 Prior to initial market rumours
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723231049/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
Illumynt Reports Q3 2025 Business Update17.10.2025 14:39:00 CEST | Press release
Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom